A(3-amyloid plaques and cerebral amyloid angiopathy (CAA) in the brain are pathological hallmarks of Alzheimer's disease (AD) and vascular dementia. The spreading of A(3 amyloidosis in the brain appears to be mediated by a seeding mechanism, where preformed fibrils (called seeds) accelerate A(3 fibril formation by bypassing the rate-determining nucleation step. Several studies have demonstrated that A(3 amyloidosis can be induced in transgenic mice, producing human A(3, by injecting A(3-rich brain extracts (seeds) derived from transgenic mice and human AD brains. However, studies on recombinant seeds are limited. Therefore, we investigated the seeding activity of pure recombinant human A(3 fibrils of different compositions. Seeds were inoculated into APP23 mice at the age of 3 months and were analyzed after 6 months of incubation. Recombinant fibril seeds made from A(3-peptides with an N-terminal methionine (i.e. (preformed fibrils from A(3M1-42, A(3M1-40, and A(3M1-40 +A(3M1-42) accelerated A(3-amyloid plaque formation in vivo compared to non-inoculated transgenic control mice of the same age. In addition, all seeds induced CAA pathology. Interestingly, A(3M1-42 containing seeds produced significantly more CAA and amyloid plaques than seeds containing pure A(3M1-40, which was surprising given that APP23 mice produce approximately four-fold more A(31-40 substrate than A(31-42. This study showed that A(3M1-42 fibrils are highly potent in seeding CAA and implies that conformational templating occurs in amyloid plaque as deduced by comparative amyloid ligand staining. Our results verify that recombinant A(3 fibrils are transmissible amyloids, and that in vivo seeding can accelerate, and redirect A(3 amyloidosis patterns compared to spontaneous age dependent amyloidosis. (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Funding Agencies|Wallenberg Center of Molecular Medicine; Swedish Brain Foundation [ALZ2019-0004, ALZ2022-0004]; Swedish Research Council [2023-03931]; Gustav V and Drottning Viktorias Foundation